IP Library Patent Application 18414094
Patent Application
App. No. 18/414,094

GLUCOSE LEVEL MANAGEMENT WITHOUT CARBOHYDRATE COUNTING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/414,094
Abstract

Disclosed herein are techniques related to glucose level management without carbohydrate counting. The techniques may involve obtaining contextual information for food intake, predicting impact of carbohydrates on a patient's glucose included in the food intake during a duration of time based at least in part on the contextual information for the food intake, determining one or more amounts of insulin to counteract the predicted impact on the patient's glucose, and affecting insulin therapy based on outputting information indicative of the determined one or more amounts of insulin.

Claims (41)

1 . A system for glucose level management without carbohydrate counting, the system comprising:

one or more processors; and

one or more processor-readable storage media storing instructions which, when executed by the one or more processors, cause performance of:

obtaining contextual information for food intake;

predicting impact of carbohydrates on a patient's glucose included in the food intake during a duration of time based at least in part on the contextual information for the food intake;

determining one or more amounts of insulin to counteract the predicted impact on the patient's glucose; and

affecting insulin therapy based on outputting information indicative of the determined one or more amounts of insulin.

2 . The system of claim 1 , wherein the impact of carbohydrates on the patient's glucose is predicted using a physiological model trained, using a machine learning technique, based on glucose sensor data of the patient and meal bolus data for one or more previous meals consumed by the patient.

3 . The system of claim 1 , wherein the impact of carbohydrates on the patient's glucose included in the food intake comprises a first amount of glucose to be absorbed into a bloodstream of the patient at a first time instance within the duration of time, and a second amount of glucose to be absorbed into the bloodstream at a second time instance within the duration of time.

4 . The system of claim 1 , wherein the one or more processor-readable storage media further store instructions which, when executed by the one or more processors, cause performance of:

prior to predicting the impact of carbohydrates on the patient's glucose included in the food intake, determining a correlation between contextual information for one or more previous meals and amounts of glucose absorbed into a bloodstream of the patient over a duration of time due to consumption of the one or more previous meals, wherein determining the correlation is performed without information from the patient relating to carbohydrates consumed from the one or more previous meals.

5 . The system of claim 1 , wherein determining the one or more amounts of insulin comprises:

obtaining an insulin sensitivity factor for the patient; and

determining the one or more amounts of insulin to counteract the predicted impact of carbohydrates on the patient's glucose included in the food intake based on the insulin sensitivity factor.

6 . The system of claim 1 , wherein determining the one or more amounts of insulin comprises utilizing a mathematical model to predict a glycemic response of the patient based on a candidate amount of insulin and the predicted impact of carbohydrates on the patient's glucose over the duration of time.

7 . The system of claim 1 , wherein determining the one or more amounts of insulin comprises using an artificial intelligence technique to determine a dosage of insulin that corresponds to a maximum amount of time for the patient's glucose levels to be within a target range.

8 . The system of claim 1 , wherein predicting the impact of carbohydrates on the patient's glucose included in the food intake comprises utilizing one or more of a group comprising a statistical averaging technique, a pattern matching technique, or a machine learning technique.

9 . The system of claim 1 , wherein the contextual information comprises one or more of a group comprising a time of day, a day of week, or a patient location.

10 . The system of claim 1 , wherein affecting the insulin therapy comprises:

communicating towards an insulin delivery device the information indicative of the determined one or more amounts of insulin.

11 . The system of claim 10 , wherein the insulin delivery device is an injection device configured to automatically set an insulin level based on the information indicative of the determined one or more amounts of insulin.

12 . The system of claim 10 , wherein the insulin delivery device is an insulin pump configured to automatically deliver the determined one or more amounts of insulin to the patient.

13 . A processor-implemented method for glucose level management without carbohydrate counting, the method comprising:

obtaining contextual information for food intake;

predicting impact of carbohydrates on a patient's glucose included in the food intake during a duration of time based at least in part on the contextual information for the food intake;

determining one or more amounts of insulin to counteract the predicted impact on the patient's glucose; and

affecting insulin therapy based on outputting information indicative of the determined one or more amounts of insulin.

14 . The method of claim 13 , wherein the impact of carbohydrates on the patient's glucose is predicted using a physiological model trained, using a machine learning technique, based on glucose sensor data of the patient and meal bolus data for one or more previous meals consumed by the patient.

15 . The method of claim 13 , further comprising prior to predicting the impact of carbohydrates on the patient's glucose included in the food intake, determining a correlation between contextual information for one or more previous meals and amounts of glucose absorbed into a bloodstream of the patient over a duration of time due to consumption of the one or more previous meals, wherein determining the correlation is performed without information from the patient relating to carbohydrates consumed from the one or more previous meals.

16 . The method of claim 13 , wherein determining the one or more amounts of insulin comprises:

obtaining an insulin sensitivity factor for the patient; and

determining the one or more amounts of insulin to counteract effects of the predicted impact of carbohydrates on the patient's glucose included in the food intake based on the insulin sensitivity factor.

17 . The method of claim 13 , wherein determining the one or more amounts of insulin comprises utilizing a mathematical model to predict a glycemic response of the patient based on a candidate amount of insulin and the predicted impact of carbohydrates on the patient's glucose included in the food intake over the duration of time.

18 . The method of claim 13 , wherein predicting the impact of carbohydrates on the patient's glucose included in the food intake comprises utilizing one or more of a group comprising a statistical averaging technique, a pattern matching technique, or a machine learning technique.

19 . The method of claim 13 , wherein affecting the insulin therapy comprises:

communicating towards an insulin delivery device the information indicative of the determined one or more amounts of insulin.

20 . One or more non-transitory processor-readable storage media storing instructions which, when executed by one or more processors, cause performance of:

obtaining contextual information for a food intake;

predicting impact of carbohydrates on a patient's glucose included in the food intake during a duration of time based at least in part on the contextual information for the food intake;

determining one or more amounts of insulin to counteract the predicted impact on the patient's glucose; and

affecting insulin therapy based on outputting information indicative of the determined one or more amounts of insulin.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2024
From: JIANG, BOYI; ZHONG, YUXIANG; AGRAWAL, PRATIK J.; DIANATY, ALI
To: MEDTRONIC MINIMED, INC.
Reel/Frame 066152/0117 →